Garnham J C, Raymond K, Shotton E, Turner P
Eur J Clin Pharmacol. 1975 Feb 28;8(2):107-13. doi: 10.1007/BF00561558.
Plasma indomethacin levels have been compared in 10 subjects following 100 mg of indomethacin from two different formulations, with similar disintegration and dissolution profiles. In four of these ten subjects plasma indomethacin levels were estimated after pretreatment with, and concurrent administration of, a buffered aspirin. The percentage of protein binding of indomethacin in the presence of salicylate was also estimated. No significant differences between peak plasma indomethacin levels with or without buffered aspirin were detected, but the rate of indomethacin absorption as shown by plasma levels, was significantly increased by pretreatment with and concurrent administration of, buffered aspirin. This was associated with a marked increase in side effects.
对10名受试者服用两种不同制剂的100毫克吲哚美辛后的血浆吲哚美辛水平进行了比较,这两种制剂具有相似的崩解和溶解曲线。在这10名受试者中的4名中,在使用缓冲阿司匹林预处理并同时给药后,对血浆吲哚美辛水平进行了估计。还估计了在水杨酸盐存在下吲哚美辛的蛋白结合百分比。未检测到服用或未服用缓冲阿司匹林时血浆吲哚美辛峰值水平之间的显著差异,但血浆水平显示,缓冲阿司匹林预处理并同时给药可显著提高吲哚美辛的吸收速率。这与副作用的显著增加有关。